What is peptide therapy? A source-led beginner's guide
What is peptide therapy?
Peptide therapy involves using short chains of amino acids, known as peptides, to affect specific biological functions in the body. Peptides occur naturally and can act as hormones, signaling molecules, or components of proteins. Some peptides are developed as prescription drugs for targeted medical purposes, while others are created for individual patients by compounding pharmacies. This guide explains the basics of peptide therapy, the difference between FDA-approved peptide medicines and compounded products, and what to consider before using peptide therapy.
For those unfamiliar with the subject or who have seen peptides mentioned in wellness contexts, this article clarifies what peptide therapy means, summarizes the current scientific understanding, and explains why regulatory differences are important.
Understanding peptides and their medical uses
Peptides are amino-acid chains that occupy a range between small molecules and larger proteins. Individual peptides have different biological functions, so the effects of one peptide cannot be generalized to the entire class. A 2020 review by Zhang and colleagues examined therapeutic peptide products and formulations approved by regulators in the United States, Europe, and Japan (Zhang et al., 2020).
Peptide medicines are developed as individual products for specific targets and uses. The 2020 review found approved therapeutic peptides in several dosage forms and noted that injections remain the most common route of administration (Zhang et al., 2020). That record of approved products does not show that every peptide is effective or safe for every proposed use.
Regulators have approved a range of peptide-based products, while other candidates remain investigational. Information about registered ongoing and completed studies is available at ClinicalTrials.gov, but a registry entry does not by itself establish that a product works.
What is peptide therapy in clinics and wellness settings?
Outside of regulated medical use, “peptide therapy” often refers to a range of products and protocols offered by clinics, telehealth providers, or wellness centers. These may include:
- FDA-approved peptides for specific conditions, such as GLP-1 agonists for diabetes or obesity, or parathyroid hormone analogs for osteoporosis
- Compounded peptides, prepared under applicable federal and state compounding rules when a patient’s medical needs cannot be met by an approved product, or in certain other circumstances permitted by law (FDA: Human Drug Compounding)
- Research-use-only peptides, which are not approved for human use and are typically labeled accordingly
Not all peptides used in “peptide therapy” are approved medicines. Some clinics may use compounded peptides, which have a different regulatory status from FDA-approved drugs. Others may market peptides for uses that lack strong clinical evidence.
FDA-approved peptide medicines vs. compounded peptides
FDA-approved peptide medicines
An FDA-approved peptide drug has been evaluated by the agency for safety, effectiveness, and manufacturing quality for a specific use. Approval is product- and indication-specific. Examples include:
- GLP-1 receptor agonists (such as semaglutide or liraglutide) for type 2 diabetes or obesity
- Parathyroid hormone analogs for osteoporosis
- Some peptide-based cancer treatments
These medicines require a prescription and are subject to strict controls for testing, labeling, and quality.
Compounded peptide products
Drug compounding generally involves combining, mixing, or altering ingredients to create a medication tailored to a patient’s needs. Depending on the legal pathway, compounding may be performed by a licensed pharmacist or physician, or by an outsourcing facility under a pharmacist’s supervision (FDA: Human Drug Compounding).
Key points about compounded peptides:
- Not FDA-approved: The FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. Their regulatory status must not be presented as equivalent to an approved medicine (FDA: Human Drug Compounding).
- Used for particular needs: Compounding can serve patients whose medical needs cannot be met by an FDA-approved drug. Federal law also addresses other limited circumstances, including certain drug-shortage situations.
- Risks: Poor compounding practices can lead to contamination or incorrect strength. Oversight differs according to whether a product is compounded under section 503A or by a registered outsourcing facility under section 503B.
If a clinic suggests a compounded peptide, ask whether an FDA-approved alternative exists and why compounding is recommended. Details on compounding regulations are available at the FDA’s compounding information.
Research-use-only peptides
Some peptides are sold online with labels such as “for research use only” or “not for human consumption.” Such a label does not establish FDA approval, pharmaceutical quality, or suitability for patient care. A research-use product should not be treated as a substitute for an approved drug or a lawfully compounded medication.
What does the evidence say about peptide therapy?
The amount and quality of evidence depend on the exact product, dose, route, population, and proposed use. Evidence supporting one approved peptide drug cannot be transferred automatically to another peptide or to a different indication. Other candidates are still being researched and may have limited or mixed results.
The review by Zhang and colleagues documents a range of approved therapeutic peptide formulations, while ClinicalTrials.gov lists investigational work (Zhang et al., 2020). Neither source supports treating “peptide therapy” as one intervention with one evidence rating. Claims made in wellness or anti-aging marketing must be checked against evidence for the exact product and use.
Before starting peptide therapy, ask about the peptide’s intended use and the strength of the supporting evidence. Clinical studies can be found at ClinicalTrials.gov.
Safety, regulation, and realistic expectations
Safety considerations
- FDA-approved peptides: These have been reviewed for their approved uses. Evidence and labeling for an approved use do not automatically apply to a different, unapproved use.
- Compounded peptides: These are not reviewed by the FDA for each formulation. Risks include contamination, dosing errors, and inconsistent quality [FDA, 2026].
- Research-use-only products: These are not meant for human use and may pose serious health risks.
Regulation
- FDA oversight: The FDA regulates approved peptide drugs and sets guidelines for compounding. Compounded drugs must meet certain requirements but are not individually approved [FDA, 2026].
- State laws: States may have additional rules for compounding pharmacies and prescribing.
Setting realistic expectations
- Peptide therapy has limits: Broad claims about anti-aging, weight loss, or performance cannot be inferred merely because a product is a peptide. Check the evidence and regulatory status for the exact product and proposed use.
- Results can vary: How someone responds to peptide therapy depends on the peptide, their health, and product quality.
- Consult a licensed provider: Work with a qualified healthcare professional who can explain the risks, benefits, and regulatory status of any peptide therapy.
For information on clinics and doctors, see the clinic directory at https://mypeptide.club/ and the doctor directory at https://toppeptideslist.com/.
Frequently asked questions
How can I check if a peptide medicine is FDA-approved?
Ask your healthcare provider for the exact name of the peptide and its approved use. You can also search the FDA’s Drugs@FDA database or look up clinical studies at ClinicalTrials.gov.
Are compounded peptides safe?
Compounded peptides can serve a medical need when an approved product is not appropriate, but the FDA does not conduct premarket review of each compounded formulation. Poor compounding can lead to contamination or incorrect strength. Discuss the reason for compounding and the applicable quality controls with your provider.
What questions should I ask before starting peptide therapy?
- Is the peptide FDA-approved for this use, or is it compounded?
- What evidence supports its use for my condition?
- What side effects are known, and how will monitoring be handled?
- Where does the peptide come from, and how is quality controlled?
Is peptide therapy covered by insurance?
Insurance coverage depends on the peptide, its approved use, and your plan. Compounded peptides and off-label uses are less likely to be covered.
Where can I find updates on laws and regulations?
See the legal section at https://safepeptides.us/ for current information on peptide prescribing and compounding.
Summary
- Peptide therapy uses chains of amino acids to affect biological processes. Some peptide medicines have FDA approval for specific conditions, while others are compounded for individual patients.
- Compounded peptides are not FDA-approved and have different premarket review and oversight from approved medicines.
- Evidence must be evaluated for each product and use. A drug approval, review article, or trial-registry entry about one peptide does not validate unrelated peptide products.
- Always consult a licensed healthcare provider before starting peptide therapy, and ask about product quality, safety, and regulatory status.
For more educational resources, visit the Peptide Atlas blog. For research updates, see https://peptidesupdates.com/.
Sources: FDA: Human Drug Compounding, Zhang et al.: review of approved therapeutic peptide products, ClinicalTrials.gov: Peptide Therapy